Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Acceleron Pharma Inc.

    NASDAQ: XLRN · Real-Time Price · USD
    178.75
    0.00 (0.00%)
    At close: Apr 24, 2025, 3:47 PM

    Acceleron Pharma Income Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q3 2021 Q2 2021 Q1 2021
    Period Ending Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 112.76M 101.13M 112.94M
    Cost of Revenue
    		 n/a n/a n/a
    Gross Profit
    		 112.76M 101.13M 112.94M
    Operating Income
    		 -255.49M -224.09M -179.34M
    Interest Income
    		 n/a n/a n/a
    Pretax Income
    		 -254.83M -223.62M -178.55M
    Net Income
    		 -254.85M -223.63M -178.56M
    Selling & General & Admin
    		 137.85M 113.78M 98.72M
    Research & Development
    		 230.4M 211.43M 193.55M
    Other Expenses
    		 n/a n/a n/a
    Operating Expenses
    		 368.25M 325.21M 292.28M
    Interest Expense
    		 n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 368.25M 325.21M 292.28M
    Income Tax Expense
    		 18K 14K 10K
    Shares Outstanding (Basic)
    		 60.94M 60.72M 60.58M
    Shares Outstanding (Diluted)
    		 60.94M 60.72M 60.58M
    EPS (Basic)
    		 -4.21 -3.71 -3
    EPS (Diluted)
    		 -4.21 -3.71 -3
    EBITDA
    		 -250.61M -219.65M -174.68M
    EBIT
    		 -255.49M -224.09M -160.43M
    Depreciation & Amortization
    		 4.23M 3.97M 3.88M

    Add to Watchlist